The Korean Journal of Medicine

The Korean Association of Internal Medicine (대한내과학회)
권호 표지
DOI QR코드

DOI QR Code

The Surgical Risk in Patients with Liver Disease

간질환 환자의 수술 위험도 판정

  • Lee, June-Sung (Department of Internal Medicine, Ilsan Paik Hospital, Inje University College of Medicine)
  • 이준성 (인제대학교 의과대학 일산백병원 내과)
  • Published : 2012.02.01
⟨ Previous Next ⟩

Abstract

Surgical procedures and administration of anesthesia can reduce blood flow to the liver. The reduction in blood flow can result in asymptomatic elevation of serum liver biochemical tests postoperatively in patients with normal liver function, but in patients with compromised liver function, hepatic decompensation can occur, leading to morbidity and mortality. Liver disease is common and patients with liver disease are frequently asymptomatic, the preoperative assessment of all patients undergoing surgery must do a careful history and physical examination to uncover risk factors and evidence of liver dysfunction. Operative risk correlates with the severity of the underlying liver disease and the nature of the surgical procedure. This review will consider the factors that contribute to peri-operative hepatic dysfunction and prediction of operative risk in patients with liver disease undergoing surgery other than liver transplantation.

Keywords

References

  1. Friedman LS. The risk of surgery in patients with liver disease. Hepatology 1999;29:1617-1623. https://doi.org/10.1002/hep.510290639
  2. Gholson CF, Provenza JM, Bacon BR. Hepatologic considerations in patients with parenchymal liver disease undergoing surgery. Am J Gastroenterol 1990;85:487-496.
  3. Gelman S. General anesthesia and hepatic circulation. Can J Physiol Pharmacol 1987;65:1762-1779. https://doi.org/10.1139/y87-276
  4. Sato K, Kawamura T, Wakusawa R. Hepatic blood flow and function in elderly patients undergoing laparoscopic cholecystectomy. Anesth Analg 2000;90:1198-1202. https://doi.org/10.1097/00000539-200005000-00037
  5. Servin F, Desmonts JM, Haberer JP, Cockshott ID, Plummer GF, Farinotti R. Pharmacokinetics and protein binding of propofol in patients with cirrhosis. Anesthesiology 1988;69: 887-891. https://doi.org/10.1097/00000542-198812000-00014
  6. O'Leary JG, Yachimski PS, Friedman LS. Surgery in the patient with liver disease. Clin Liver Dis 2009;13:211-231. https://doi.org/10.1016/j.cld.2009.02.002
  7. Runyon BA. Surgical procedures are well tolerated by patients with asymptomatic chronic hepatitis. J Clin Gastroenterol 1986;8:542-544. https://doi.org/10.1097/00004836-198610000-00010
  8. Hanje AJ, Patel T. Preoperative evaluation of patients with liver disease. Nat Clin Pract Gastroenterol Hepatol 2007; 4:266-276.
  9. Lee HS. Preoperative evaluation and managment in patients with liver cirrhosis. In: Kim CY, ed. Digestive Disease. Seoul: Ilchokak, 2005:565-571
  10. Frye JW, Perri RE. Perioperative risk assessment for patients with cirrhosis and liver disease. Expert Rev Gastroenterol Hepatol 2009;3:65-75. https://doi.org/10.1586/17474124.3.1.65
  11. Krok KL, Munoz SJ. Management of autoimmune and cholestatic liver disorders. Clin Liver Dis 2009;13:295-316. https://doi.org/10.1016/j.cld.2009.02.011
  12. Child CG, Turcotte JG. Surgery and portal hypertension. Major Probl Clin Surg 1964;1:1-85.
  13. Garrison RN, Cryer HM, Howard DA, Polk HC Jr. Clarification of risk factors for abdominal operations in patients with hepatic cirrhosis. Ann Surg 1984;199:648-655. https://doi.org/10.1097/00000658-198406000-00003
  14. Mansour A, Watson W, Shayani V, Pickleman J. Abdominal operations in patients with cirrhosis: still a major surgical challenge. Surgery 1997;122:730-735. https://doi.org/10.1016/S0039-6060(97)90080-5
  15. O'Leary JG, Friedman LS. Predicting surgical risk in patients with cirrhosis: from art to science. Gastroenterology 2007;132:1609-1611. https://doi.org/10.1053/j.gastro.2007.03.016
  16. Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001;33:464-470. https://doi.org/10.1053/jhep.2001.22172
  17. Wiesner R, Edwards E, Freeman R, et al. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology 2003;124:91-96. https://doi.org/10.1053/gast.2003.50016
  18. Teh SH, Nagorney DM, Stevens SR, et al. Risk factors for mortality after surgery in patients with cirrhosis. Gastroenterology 2007;132:1261-1269. https://doi.org/10.1053/j.gastro.2007.01.040